CA2087270C - Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus - Google Patents

Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus Download PDF

Info

Publication number
CA2087270C
CA2087270C CA002087270A CA2087270A CA2087270C CA 2087270 C CA2087270 C CA 2087270C CA 002087270 A CA002087270 A CA 002087270A CA 2087270 A CA2087270 A CA 2087270A CA 2087270 C CA2087270 C CA 2087270C
Authority
CA
Canada
Prior art keywords
baculovirus
sequence
promoter
modified
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002087270A
Other languages
English (en)
French (fr)
Other versions
CA2087270A1 (fr
Inventor
Gerard Devauchelle
Martine Cerutti
Claire Cahoreau
Marianne Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Recherche Agronomique INRA filed Critical Centre National de la Recherche Scientifique CNRS
Publication of CA2087270A1 publication Critical patent/CA2087270A1/fr
Application granted granted Critical
Publication of CA2087270C publication Critical patent/CA2087270C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA002087270A 1990-07-18 1991-07-17 Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus Expired - Fee Related CA2087270C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR909009143A FR2664905B1 (fr) 1990-07-18 1990-07-18 Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
FR90/09143 1990-07-18
PCT/FR1991/000588 WO1992001801A1 (fr) 1990-07-18 1991-07-17 Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus

Publications (2)

Publication Number Publication Date
CA2087270A1 CA2087270A1 (fr) 1992-01-19
CA2087270C true CA2087270C (fr) 2001-12-04

Family

ID=9398840

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002087270A Expired - Fee Related CA2087270C (fr) 1990-07-18 1991-07-17 Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus

Country Status (14)

Country Link
US (1) US5571709A (no)
EP (1) EP0651815B1 (no)
JP (1) JP3076833B2 (no)
AT (1) ATE151462T1 (no)
AU (1) AU660419B2 (no)
CA (1) CA2087270C (no)
DE (1) DE69125632T2 (no)
FR (1) FR2664905B1 (no)
HU (1) HUT62937A (no)
IE (1) IE912525A1 (no)
NO (1) NO930145L (no)
NZ (1) NZ239032A (no)
PT (1) PT98357B (no)
WO (1) WO1992001801A1 (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400382B (de) * 1994-06-24 1995-12-27 Inject Star Poekelmasch Vorrichtung zum quetschen und auflockern von fleisch
FR2732035B1 (fr) * 1995-03-23 1997-05-30 Agronomique Inst Nat Rech Procede de regulation de l'expression d'un gene dans un baculovirus, par un site de fixation d'un recepteur de l'acide retinoique, et vecteur pour la mise en oeuvre du dit procede
JP2003040297A (ja) * 2001-08-06 2003-02-13 Toppan Printing Co Ltd オーバーキャップ付封緘キャップ
ES2516041T3 (es) 2001-10-10 2014-10-30 Ratiopharm Gmbh Remodelación y glicoconjugación de la hormona del crecimiento humano (hGH)
EP2305311A3 (en) 2001-10-10 2011-07-20 BioGeneriX AG Glycoconjugation of peptides
EP1615945B1 (en) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylation methods and proteins/peptides produced by the methods
JP4889505B2 (ja) 2004-02-02 2012-03-07 アンブレツクス・インコーポレイテツド 被修飾されたヒト成長ホルモンポリペプチドおよびこれらの使用
JP2008503217A (ja) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド 新規抗原結合ポリペプチド及びそれらの使用
CA2569381A1 (en) 2004-07-21 2006-08-31 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
WO2009100255A2 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
KR20070090023A (ko) 2004-12-22 2007-09-04 암브룩스, 인코포레이티드 변형 인간 성장 호르몬
JP2008525032A (ja) 2004-12-22 2008-07-17 アンブレツクス・インコーポレイテツド 組換えヒト成長ホルモンを発現及び精製するための方法
WO2006068802A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF
KR101224781B1 (ko) 2004-12-22 2013-01-21 암브룩스, 인코포레이티드 비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물
WO2006069246A2 (en) 2004-12-22 2006-06-29 Ambrx, Inc. Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
CA2609205A1 (en) * 2005-06-03 2006-12-14 Ambrx, Inc. Improved human interferon molecules and their uses
AU2005335491B2 (en) * 2005-08-18 2010-11-25 Ambrx, Inc. Compositions of tRNA and uses thereof
ATE500215T1 (de) * 2005-11-08 2011-03-15 Ambrx Inc Beschleuniger für die modifikation nichtnatürlicher aminosäuren und nichtnatürlicher aminosäurepolypeptide
ES2547554T3 (es) * 2005-11-16 2015-10-07 Ambrx, Inc. Métodos y composiciones que comprenden aminoácidos no naturales
KR101423898B1 (ko) * 2005-12-14 2014-07-28 암브룩스, 인코포레이티드 비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
CN101541955B (zh) 2006-09-08 2016-09-28 Ambrx公司 用于脊椎动物细胞的杂合抑制tRNA
EP2069396B1 (en) 2006-09-08 2015-10-21 Ambrx, Inc. Modified human plasma polypeptide or fc scaffolds and their uses
PT2064333E (pt) 2006-09-08 2014-06-09 Ambrx Inc Supressor híbrido arnt para células de vertebrados
PL2068909T3 (pl) 2007-03-30 2012-09-28 Ambrx Inc Modyfikowane polipeptydy fgf-21 i ich zastosowanie
EP2076533B1 (en) 2007-05-02 2014-10-08 Ambrx, Inc. Modified interferon beta polypeptides and their uses
ES2632504T3 (es) 2007-11-20 2017-09-13 Ambrx, Inc. Polipéptidos de insulina modificados y sus usos
JP5680534B2 (ja) 2008-07-23 2015-03-04 イーライ リリー アンド カンパニー 修飾されているウシｇ−ｃｓｆポリペプチドおよびそれらの使用
PE20110832A1 (es) 2008-09-26 2011-11-24 Ambrx Inc Polipeptidos de eritropoyetina felina modificados
MX348657B (es) 2008-09-26 2017-06-21 Ambrx Inc Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
WO2010117786A1 (en) * 2009-03-30 2010-10-14 Mount Sinai School Of Medicine Of New York University Influenza virus vaccines and uses thereof
AU2010254136B2 (en) 2009-05-26 2016-09-29 Mount Sinai School Of Medicine Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
WO2010144794A1 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Baculovirus-expressed fusion polypeptide vaccines with enhanced immunogenicity and uses thereof
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
EA201290541A1 (ru) 2009-12-21 2013-05-30 Амбркс, Инк. Модифицированные бычьи соматотропиновые полипептиды и их применение
CN102666578A (zh) 2009-12-21 2012-09-12 Ambrx公司 经过修饰的猪促生长素多肽和其用途
EP2536425B1 (en) 2010-02-18 2019-06-19 Icahn School of Medicine at Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
AU2011235220B2 (en) 2010-03-30 2016-03-10 Mount Sinai School Of Medicine Influenza virus vaccines and uses thereof
WO2011156594A2 (en) 2010-06-09 2011-12-15 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment
CA2808596C (en) 2010-08-17 2020-12-15 Ambrx, Inc. Modified relaxin polypeptides and their uses
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
RU2632651C2 (ru) 2011-05-11 2017-10-06 Чилдрен'С Медикал Сентер Корпорейшн Модифицированный биотин-связывающий белок, слитые белки на его основе и их применение
IN2014CN00688A (no) * 2011-07-27 2015-04-03 Genethon
US10131695B2 (en) 2011-09-20 2018-11-20 Icahn School Of Medicine At Mount Sinai Influenza virus vaccines and uses thereof
JP2016508133A (ja) 2012-12-18 2016-03-17 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルスワクチン及びその使用
EP3511417B1 (en) 2013-01-28 2023-05-31 Kansas State University Research Foundation Rift valley fever virus glycoproteins, gn and gc, and their use
WO2014159960A1 (en) 2013-03-14 2014-10-02 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
JP6702962B2 (ja) 2014-10-24 2020-06-03 ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ 改変ｆｇｆ−２１ポリペプチドおよびその使用
JP2018504412A (ja) 2015-01-23 2018-02-15 アイカーン スクール オブ メディシン アット マウント サイナイ インフルエンザウイルスワクチン接種レジメン
CA3023143A1 (en) 2016-06-15 2017-12-21 Icahn School Of Medicine At Mount Sinai Influenza virus hemagglutinin proteins and uses thereof
CN110637027A (zh) 2017-02-08 2019-12-31 百时美施贵宝公司 包含药代动力学增强子的修饰的松弛素多肽及其用途
WO2018187706A2 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
AT519931A1 (de) * 2017-05-12 2018-11-15 Kepler Univ Gmbh Herstellung von armierter DNA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE78293T1 (de) * 1983-05-27 1992-08-15 Texas A & M Univ Sys Verfahren zur herstellung eines rekombinanten baculovirus-expressionsvektors.

Also Published As

Publication number Publication date
AU8232491A (en) 1992-02-18
NO930145D0 (no) 1993-01-15
EP0651815A1 (fr) 1995-05-10
PT98357B (pt) 1999-01-29
PT98357A (pt) 1992-05-29
HU9300118D0 (en) 1993-04-28
DE69125632T2 (de) 1997-10-23
WO1992001801A1 (fr) 1992-02-06
FR2664905B1 (fr) 1994-08-12
JPH06500010A (ja) 1994-01-06
CA2087270A1 (fr) 1992-01-19
JP3076833B2 (ja) 2000-08-14
NZ239032A (en) 1993-10-26
ATE151462T1 (de) 1997-04-15
HUT62937A (en) 1993-06-28
EP0651815B1 (fr) 1997-04-09
DE69125632D1 (de) 1997-05-15
FR2664905A1 (fr) 1992-01-24
IE912525A1 (en) 1992-01-29
US5571709A (en) 1996-11-05
NO930145L (no) 1993-03-15
AU660419B2 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
CA2087270C (fr) Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus
EP0345152B1 (fr) Baculovirus modifié, son procédé de préparation et son application en tant que vecteur d'expression de gènes
EP0449923B1 (fr) Procede de recombinaison in vivo de sequences d'adn partiellement homologues
EP0870046B1 (fr) Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
WO1998013485A1 (en) Methods for optimization of gene therapy by recursive sequence shuffling and selection
FR2705686A1 (fr) Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
CA2266423A1 (en) Methods for optimization of gene therapy by recursive sequence shuffling and selection
JPH11506612A (ja) Ａａｖ特異的標的化組込み
US5482853A (en) Position-specific insertion vectors and method of using same
Ozers et al. TheEnv-like Open Reading Frame of the Baculovirus-Integrated Retrotransposon TED Encodes a Retrovirus-like Envelope Protein
Roy et al. Baculovirus multigene expression vectors and their use for understanding the assembly process of architecturally complex virus particles
FR2784394A1 (fr) Cassette d'integration-excision
MXPA04008753A (es) Baculovirus disenados y su uso.
EP3494127B1 (fr) Système d'expression baculovirus
Strauss et al. Efficient oligodeoxyribonucleotide-directed deletion mutagenesis using pEMBL vectors: removal of early region introns from polyoma virus mutants
WO2001098453A2 (fr) Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane
EP0305229B1 (fr) Vecteur viral et ADN recombinant codant pour une ou des protéines de structure (HA, F et/ou NP), d'un morbillivirus.
EP0771872A1 (fr) Procédé de polymèrisation de séquences d'acides nucléiques et ses applications
JPH01157393A (ja) 酵母における安定なゲノム組込みおよび外来コーディング配列の発現
FR2656531A1 (fr) Promoteur artificiel pour l'expression de proteines dans le levure.
FR2743818A1 (fr) Constructions d'adn et vecteurs d'expression derives du gene de l'arn va i d'adenovirus
WO1999009194A1 (fr) Adenovirus aviaire celo recombinant et son utilisation comme vecteur vaccinant
EP2205747A1 (fr) Souches e. coli attenuees invasives et leurs applications comme vecteur intracellulaire de molecule therapeutique
WO2005010038A2 (fr) Peptide inhibiteur de la traduction des proteines et ses utilisations pour le controle de la traduction des proteines
JPH05301895A (ja) ハイブリッド抗原タンパク質、それを発現する組み換えウイルス、及びその製造方法

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed